93 related articles for article (PubMed ID: 2349203)
41. Aspirin use in the prevention of cardiovascular events.
Crutcher JM; Mallonee S; Daniels C
J Okla State Med Assoc; 2007 Oct; 100(10):383-7. PubMed ID: 18085095
[TBL] [Abstract][Full Text] [Related]
42. [Possibilities for the active prevention of vascular diseases. A pilot study with factory workers].
Einfeldt H; Milz H; Wimmer PP
MMW Munch Med Wochenschr; 1979 Mar; 121(11):387-8. PubMed ID: 107410
[No Abstract] [Full Text] [Related]
43. Aspirin and myocardial infarction study.
Cooper EE
Tex Med; 1975 Oct; 71(10):84-5. PubMed ID: 1188665
[No Abstract] [Full Text] [Related]
44. Recent developments in secondary prevention of stroke.
Sandercock PA
Scott Med J; 1993 Jun; 38(3 Suppl):S10-1. PubMed ID: 8356434
[No Abstract] [Full Text] [Related]
45. [Acetylsalicylic acid and myocardial infarction].
Heikinheimo R
Duodecim; 1977; 93(19):1183-5. PubMed ID: 590152
[No Abstract] [Full Text] [Related]
46. The Million Hearts initiative: applying the ABCS of healthy hearts in North Carolina.
Simpson C; Massing M; Simpson RJ
N C Med J; 2012; 73(6):476-80. PubMed ID: 23617165
[TBL] [Abstract][Full Text] [Related]
47. Primary prevention of stroke.
Chockalingam A
Health Rep; 1994; 6(1):73-5. PubMed ID: 7919092
[No Abstract] [Full Text] [Related]
48. Heart attack prevention: trust the old reliables.
Harv Health Lett; 2003 Nov; 29(1):7. PubMed ID: 14633500
[No Abstract] [Full Text] [Related]
49. [General characteristics and evaluation of the degree of ischemic heart disease risk factors in workers at Wrocław plants included in the program of primary prevention].
Lukasik S; Bartkowiak A; Chwistecki K; Nowosad H; Morgonstern W; Goździk H
Przegl Lek; 1985; 42(6):516-9. PubMed ID: 4070659
[No Abstract] [Full Text] [Related]
50. Aspirin and primary prophylaxis in myocardial infarction.
Horton RC; Kendall MJ
Lancet; 1989 Sep; 2(8666):800. PubMed ID: 2571034
[No Abstract] [Full Text] [Related]
51. [Primary prevention of acute myocardial infarction with aspirin].
Agustí A; Diogène E
Med Clin (Barc); 2004 Apr; 122(15):592-4. PubMed ID: 15144749
[No Abstract] [Full Text] [Related]
52. Aspirin and prevention of myocardial infarction.
Mayo NE; Levy AR
Lancet; 1990 Oct; 336(8722):1069. PubMed ID: 1977041
[No Abstract] [Full Text] [Related]
53. [Calculation of the size of the population group necessary for evaluation of the results of measures for the prevention of cardiovascular diseases (on the example of the Kaunas survey)].
Daud DE; Glazunov IS; Ianushkevichus ZI
Kardiologiia; 1977 Aug; 17(8):10-6. PubMed ID: 926549
[TBL] [Abstract][Full Text] [Related]
54. 7 strategies to prevent a heart attack. How to identify your major risk factors and diminish their danger.
Heart Advis; 2004 Mar; 7(3):1, 7. PubMed ID: 15195606
[No Abstract] [Full Text] [Related]
55. A lifetime of prevention: the case of heart failure.
Yusuf S; Pitt B
Circulation; 2002 Dec; 106(24):2997-8. PubMed ID: 12473540
[No Abstract] [Full Text] [Related]
56. Population factors not addressed in cohort study.
Woodward S; Hyams J; Tanner L; Ford E; Gray H; Yousaf N; Woodward S
Epidemiology; 2001 Mar; 12(2):282. PubMed ID: 11246597
[No Abstract] [Full Text] [Related]
57. Prophylactic aspirin treatment: the merits of timing. International Womb-to-Tomb Chronome Study Group.
Cornélissen G; Halberg F; Prikryl P; Danková E; Siegelová J; Dusek J
JAMA; 1991 Dec; 266(22):3128-9. PubMed ID: 1956095
[No Abstract] [Full Text] [Related]
58. Aspirin use and cardiovascular disease in women.
Yawn BP
JAMA; 1992 Jan; 267(3):365. PubMed ID: 1550615
[No Abstract] [Full Text] [Related]
59. [Recent examples for drug (developments) in primary, secondary and tertiary prevention].
Bramlage P; Schindler C; Schmidt AC; Bramlage CP; Kirch W
Dtsch Med Wochenschr; 2007 Oct; 132(42):2212-6. PubMed ID: 17926249
[TBL] [Abstract][Full Text] [Related]
60. Prevention of hypertension.
Dustan HP
Heart Dis Stroke; 1992; 1(6):337-9. PubMed ID: 1344128
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
